{
  "paper_metadata": {
    "pmid": "29797793",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the BRCA2 N372H polymorphism found in drug-resistant recurrent ovarian cancer patients."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "VUS",
      "patients": {
        "count": 10,
        "demographics": "10 patients with drug-resistant recurrent ovarian cancer, age range 39-70 years (median 48 years)",
        "phenotype": "drug-resistant recurrent ovarian cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 4,
        "affected_count": 4,
        "unaffected_count": 0,
        "uncertain_count": 6,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The BRCA2 N372H polymorphism was found in 40% of drug-resistant recurrent ovarian cancer patients.",
        "assays": []
      },
      "segregation_data": "Not mentioned",
      "population_frequency": "Not mentioned",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was not detected in drug-sensitive recurrent ovarian cancer patients.",
      "key_quotes": [
        "BRCA2 N372H polymorphism was found in 40% (4/10) of drug-resistant recurrent ovarian cancer patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data is based solely on the BRCA2 variant mentioned in the text."
  }
}